Dr. Marianna Truman has over 17 years of R&D experience in molecular and cell biology, biotechnology engineering, toxicology and applied research. She currently serves as a Research Associate Director at Pluri Biotech, where she leads the nonclinical cell therapy programs, focusing on the mechanism of action, pharmacokinetics and pharmacodynamics of the PLacental eXpanded (PLX) allogeneic cell product, and its pipeline development for regenerative medicine. Marianna did her postdoc at the US National Toxicology Program Laboratory (NIH/NIEHS, NC, USA) and developed 3D architecture systems suitable for high-throughput screening for kidney and liver toxicity. As a toxicologist at the Cancer Biology and Cannabinoid Research Laboratory (Biology Faculty, Technion – IIT), she explored the effects of cannabis extracts on the kidneys by developing experimental models for human renal barriers. During her PhD studies (Biotechnology and Food Engineering, Technion – IIT), Marianna investigated the mechanism of action and regulation of ferritin trafficking and secretion and discovered two molecular secretion pathways for ferritin. During her military service, Marianna served as a Research Navy Officer at the Israel Naval Medical Institute and investigated the recovery from CNS oxygen toxicity. Dr. Truman also serves as a Lecturer in Toxicology at the Technion - IIT, and has presented at conferences and congresses worldwide.